Advanced Cardiac Imaging - Clinical

Our Cardiac Imaging Services:

Our expert team of adult and pediatric cardiologists and radiologists offer a wide range of quality service to our Suffolk County communities and beyond.
Our Cardiac Computed Tomography Angiography (CCTA) service offers state of the art technology, applying two 320 row detector row and two 64 slice scanners to diagnose and evaluate coronary artery disease, both on a routine and emergent basis. With volume approaching 3,000 CCTAs, per year, the program, under the leadership of Dr. Michael Poon, MD, FACC, FSCCT, offers expert rapid, comprehensive, noninvasive assessment of chest pain to patients arriving in our Emergency Department. .

Our CCTA program also allows for increased understanding of patients’ condition when preparing for performance of complex cardiac surgeries, such as Transcutaneous Aortic Valve Implantation (TAVI), Atrial Fibrillation Radiofrequency Ablation, Transcatheter Endovascular Aortic Repair, and Lariat Procedures. The excellent views of the cardiovascular system through this noninvasive technology increase the ease with which our cardiovascular surgeons can optimize treatments for these serious, life threatening conditions.
Recently, our center has introduced the provision of tele-medicine services, increasing access to this vital, life enhancing procedure through the provision of medical expertise to smaller community centers. In our initial implementation with Mather Memorial Hospital, we have successfully provided more than 500 scans to emergency department patients. We are currently discussing how sharing of cardiovascular medical and clinical expertise can expand access even further into our communities.

In addition to CCTA, our program offers adult and pediatric Cardiac Magnetic Resonance Imaging (CMRI). We operate two new Siemens scanners (both 1.5 and 3T), as a well as a Philips 1T Open scanner, and we have recently introduced the use of a Siemens PET- MRI. Our current CMRI research focuses on the evaluation of ischemic heart disease, pulmonary hypertension, and the role of stem cell injection post myocardial infarction.